Divestment
Flowcardia
A cardiovascular medical device company specializing in endovascular systems for the treatment of chronic total occlusions (CTOs) in coronary and peripheral arteries.
Key Facts
- Sector
Life Sciences
- Country
United States
- Fund
LSP 3
- Entry
2007
- Exit
2013
- EQT Responsible Advisor
Fouad Azzam
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.
